Tag: CBT > Medical Cannabis Research Cannabinoids: Page 7

Florida

Miami Dade College Will Offer Medical Marijuana Classes

The college is developing courses on the biology and chemistry of marijuana, as well as the plant's historical usage and evolving regulation.

August 9, 2019

Compliance

Curaleaf Scrubs CBD Health Claims From Its Pages in Response to FDA Warning

Curaleaf “immediately began an extensive review of its website and social media platforms to remove all statements that FDA identified as non-compliant.”

July 29, 2019

Mergers and Acquisitions

KBL Merger Corp. IV SPAC Signs Definitive Business Combination Agreement to Acquire CannBioRx Life Sciences Corp.

CannBioRx Life Sciences Corp. programs focus on developing anti-inflammatory drugs, including scientifically developed, non-psychoactive cannabinoids that target key pathways in inflammatory diseases.

July 29, 2019

Legislation and Regulation

NJ Gov. Phil Murphy Slates Medical Marijuana Bill Signing

Gov. Phil Murphy said he will sign a measure on July 2 to dramatically expand the state’s medical marijuana program.

July 1, 2019

Legislation and Regulation

Iowa Sen. Chuck Grassley Helps Introduce Bill to Expand Marijuana, CBD Medical Research

"The government should help facilitate the scientific research needed to give these parents the answers they need," Grassley said.

July 1, 2019

Interviews & Opinion

Trait Biosciences Unveils Fully Water-Soluble Cannabinoids

The tasteless, odorless cannabinoids will more easily mix into edibles, beverages and more.

June 10, 2019

Advocacy for Cannabis Legalization

NFL and Players’ Union to Study Potential Use of Marijuana for Pain Management

The exploration will take place within a new medical committee formed by the league and union that will provide recommendations on key medical issues.

May 21, 2019

Legislation and Regulation

FDA Plans Hearings on CBD Policy

Following hemp legalization in the U.S., the FDA must now figure out how to regulate hemp-derived CBD as a food and beverage ingredient.

March 1, 2019

Industry Headlines

FSD Pharma Announces Signing of LOI With Solarvest to Develop, Test Pharma-Grade Cannabinoids Out of Algae

The pharma-grade process could reduce the production time for targeted cannabinoid molecules.

February 5, 2019

Interviews & Opinion

Using Cannabis Science to Build Customer Trust: Q&A With Andrea Sparr-Jaswa

Farma PDX’s director of education explains the benefits of losing the indica/sativa dichotomy and instead focusing on cannabinoid and terpene content.

January 23, 2019

Finance

Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp

ReFormation is developing a therapeutic to repair vital organs by combining cannabinoids and re-engineering a molecule, HMGB1.

January 16, 2019

Distribution

DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?

With the DEA signaling a willingness to join the FDA in approving certain cannabis-derived drugs for sale, the industry looks ahead to more tidal shifts.

September 28, 2018